How Kidney Disease Worsens Heart Attack Outcomes Through Hormonal Imbalances
In heart attack patients with kidney disease, neurohumoral biomarkers like aldosterone, angiotensin II, and von Willebrand factor are linked to worse outcomes.
Quick Facts
What This Study Found
Reduced kidney function in heart attack patients is associated with elevated RAAS biomarkers and endothelial dysfunction markers that worsen cardiovascular outcomes.
Key Numbers
N=106; stratified at GFR <=90 vs >90 mL/min; aldosterone and vWF significantly higher in the lower GFR group.
How They Did This
Cross-sectional study examining associations between renal function and biomarkers (aldosterone, angiotensin II, vWF) in acute MI patients.
Why This Research Matters
Understanding the hormonal crosstalk between failing kidneys and damaged hearts could identify new therapeutic targets and improve risk stratification.
The Bigger Picture
This supports the cardiorenal syndrome concept — heart and kidney disease amplify each other through shared neurohumoral pathways.
What This Study Doesn't Tell Us
Cross-sectional design cannot establish causality. Single time-point biomarker measurements may not capture dynamic changes.
Questions This Raises
- ?Would RAAS inhibition in CKD patients improve heart attack outcomes?
- ?Can these biomarkers predict which AMI-CKD patients face the highest risk?
Trust & Context
- Key Stat:
- RAAS activation Kidney dysfunction drives renin-angiotensin-aldosterone system activation that worsens cardiac remodeling
- Evidence Grade:
- Cross-sectional observational study — identifies associations but cannot prove causation. Useful for hypothesis generation.
- Study Age:
- Published in 2025, adding biomarker data to the cardiorenal syndrome evidence base.
- Original Title:
- Neurohumoral Dysregulation in Acute Myocardial Infarction With Chronic Kidney Disease: Implications for Prognosis and Management.
- Published In:
- Cureus, 17(10), e93692 (2025)
- Authors:
- Polianska, Oksana, Tashchuk, Victor, Hulaha, Olha, Olinchuk, Valentyna, Moskaliuk, Inna, Kushnir, Yevhen
- Database ID:
- RPEP-13072
Evidence Hierarchy
Watches what happens naturally without intervening.
What do these levels mean? →Frequently Asked Questions
Why does kidney disease make heart attacks worse?
Reduced kidney function activates hormonal systems (like RAAS) that cause blood vessel constriction, fluid retention, and heart remodeling, worsening cardiac outcomes.
What is von Willebrand factor?
A protein released by damaged blood vessel walls — elevated levels indicate endothelial dysfunction and increased clotting risk.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-13072APA
Polianska, Oksana; Tashchuk, Victor; Hulaha, Olha; Olinchuk, Valentyna; Moskaliuk, Inna; Kushnir, Yevhen. (2025). Neurohumoral Dysregulation in Acute Myocardial Infarction With Chronic Kidney Disease: Implications for Prognosis and Management.. Cureus, 17(10), e93692. https://doi.org/10.7759/cureus.93692
MLA
Polianska, Oksana, et al. "Neurohumoral Dysregulation in Acute Myocardial Infarction With Chronic Kidney Disease: Implications for Prognosis and Management.." Cureus, 2025. https://doi.org/10.7759/cureus.93692
RethinkPeptides
RethinkPeptides Research Database. "Neurohumoral Dysregulation in Acute Myocardial Infarction Wi..." RPEP-13072. Retrieved from https://rethinkpeptides.com/research/polianska-2025-neurohumoral-dysregulation-in-acute
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.